Back to Search
Start Over
Gut microbiota – a double-edged sword in cancer immunotherapy
- Source :
- Trends in Cancer. 9:3-5
- Publication Year :
- 2023
- Publisher :
- Elsevier BV, 2023.
-
Abstract
- Immune checkpoint blockade (ICB) has revolutionized cancer treatment. However, many patients fail to respond to this therapy or experience side effects. Recently, gut microbiota have emerged as a key determinant of ICB efficacy and toxicity, making manipulation of the microbiome a novel therapeutic strategy with which to improve ICB outcomes.
- Subjects :
- Cancer Research
Oncology
Subjects
Details
- ISSN :
- 24058033
- Volume :
- 9
- Database :
- OpenAIRE
- Journal :
- Trends in Cancer
- Accession number :
- edsair.doi.dedup.....a0098f3367d83fd9a35999fcda8c1b03